News

Webinar #3 – People-centered healthcare system: what more do we need to do? 

Register now for the next webinar titled People-centered healthcare system: what more do we need to do?, on Tuesday 28 April 2026 at 16:00-17:00 CET.

Studies estimate that approximately 50% of medications are not taken according to prescribed instructions, often because people do not fully understand how or why a treatment works. Treatment adherence therefore reflects more than individual behaviour: it also highlights gaps in how healthcare systems communicate with and support patients.

Building a more people-centred healthcare system means ensuring that information is understandable, relevant, and adapted to each individual. By tailoring communication to patients’ needs and levels of health literacy, healthcare providers can help people to better engage with their treatments.

The BEAMER project contributes to this shift through the development of B-COMPASS, a questionnaire designed to help clinicians personalize the way treatment information is delivered, ultimately improving adherence and health outcomes across Europe.

We will have the pleasure of welcoming three panelists to discuss this important issue.

  • Oana Scarlatescu, Director Strategic partnerships, healthcare systems, EFPIA, Belgium

Oana Scarlatescu is Director of Strategic Partnerships & Health Systems at EFPIA, where she leads patient engagement and partnerships with stakeholders across the health sector. She previously worked in global health and development in Geneva and holds degrees in international relations and communications.

  • Douglas Slakey, Chair of the Health Systems Innovation collaborative, Belmont University, USA

Dr. Douglas Slakey is an internationally recognized transplant surgeon, healthcare leader, and administrator dedicated to improving healthcare systems and patient outcomes. He is the best-selling author of The Process Manifesto: Improving Healthcare in a Complex World. He currently serves as Professor and Chair of Health Systems Science at Belmont University’s Frist College of Medicine, where he founded the Belmont Collaborative for Health Systems Innovation, a global hub focused on advancing research and scalable solutions to improve healthcare delivery and value across the whole-person health journey. He is also the inaugural holder of the HCA Healthcare Endowed Chair for Health Systems Science and a founder of LifePathEI, an advanced platform supporting individuals in their wellbeing journey. Previously, Dr. Slakey spent five years at Advocate Aurora Health as Chief of Surgical Services, guiding strategy and innovation across 27 hospitals. Prior to that, he served for 21 years at Tulane University, where he became Professor and Chair of Surgery and led the transplant program, pioneering advances in immunosuppression and minimally invasive surgery while improving access to care in the Gulf South.

Dr. Slakey has authored more than 150 peer-reviewed publications and numerous abstracts, serves on several medical journal editorial boards, and holds degrees from UC Berkeley (BA, MPH) and the Medical College of Wisconsin (MD), with further training at the University of Oxford and Johns Hopkins.

  • Sofia Trantza, Assessor of the Evaluation Division, Medicinal products, Greek National Drug Authority, Greece

Sofia Trantza is a pharmacist, specialisedd in Pharmaceutical Technology and Pharmacovigilance and certified in the field of Medical Affairs. She recently completed her studies (CAS) in the field of Radiopharmaceuticals at the ETH University of Zurich, Switzerland. She holds a certification for the Safety of Cosmetics from the University of VUB in Belgium. She has over 7 years of experience as a Person Responsible for Pharmacovigilance (QPPV) in the Pharmaceutical Industry and is simultaneously certified according to ISO 9001: 2008, 2015 and ISO 13485. She joined the National Medicines Organization (EOF) in 2016, served as an employee in the Adverse Reactions Department and as an alternate member of the European Pharmacovigilance Committee (PRAC) for Greece. She held the position of PRAC member, representing Greece at the European Medicines Agency (EMA), until December 2024, is an Assessor in the Department for the Evaluation of Medicinal Products for Human Use and is a pharmacist in the Cosmetics Department and in the Standing European Committee on Cosmetics and the relevant working groups. Recently she has been accepted in the MSc of Software Engineering and will study Artificial Intelligence in the University of Quantic, USA. 

Facebook
X
LinkedIn
Pinterest
Email
Threads
Print

We Would Be Happy to Hear Your Comments

Feel free to share your thoughts by contacting us

Contact Us

Healthcare Professional

The primary aim of the end user personas is to support the creation of materials to support the implementation of the BEAMER model framework and to help define requirements for the elements of the BEAMER model framework. Hence, healthcare professionals (HCPs) represent the primary envisaged end user group of the BEAMER model framework and the associated Adherence Intelligence Visualisation Platform (AIVP)

It is one learning from the joint design process that the job titles of healthcare professional team members do not necessarily predict the roles they would play within the change management process for implementing BEAMER and installing it as a standard model within healthcare. Additionally, the role and responsibilities of certain job titles, for example nurse, varies across different healthcare systems and would affect how they interact with the BEAMER model outputs and the access they would be permitted and so it would not be helpful to include these job titles: The four personas represent role-independent archetypes within the group of HCPs. They encompass a Managerial HCP Persona, an Implementer HCP Persona, a Support HCP Persona, and a Established HCP Persona.

These healthcare professional personas may be further tailored to specific healthcare settings depending on the needs of the individual pilot sites. Thus, adapted or spin-off versions of these original personas may be considered. The persona displays include a summarising statement, goals, challenges, experience, and needs to enhance the accessibility and usability of the model while minimising user burden.

Close the popup

Patient Organisation

Patient organisations are considered potential users of the model outputs. Consequently, personas were designed for these groups to assure that the implementation materials may also support their needs in the longer term, thus fostering sustainability of the project outputs.

The identified focus areas within this persona are goals, needs, skills and tools, along with potential challenges anticipated during the implementation process. The persona emphasises awareness-raising, capacity building, education, peer support provision, and the promotion of research and development in therapeutic care.

The patient organisation persona serves as a theoretical framework representing how patient organisations could benefit from and include the BEAMER model framework in their therapy and care related as well as their organisational work. This persona comprises the needs, goals, challenges and necessary tools, facilitating preparation and implementation of the model and optimising the user experience of patient organisations as end users of the BEAMER model framework. It can be used as a guide to identify potential obstacles and understand the prerequisites for a patient organisation to successfully adopt and integrate the BEAMER model framework.

“In implementing the BEAMER model, we want to be able to respond to the different needs of our patients to ensure their adherence, build a supportive community and improve outcomes.”

Close the popup